In a recent study published in New England Journal of Medicine, Pan and colleagues1 faced an important aspect for prevention of hepatitis B virus (HBV) infection: antiviral treatment with Tenofovir (TDF) during pregnancy to reduce perinatal transmission. This route of infection plays a crucial role for global diffusion of HBV, with frequency of chronic infection in mother-to-childtransmission (MTCT) of 90%
Antiviral treatment of HBV positive pregnant women: an additional tool to reduce perinatal transmission / Bruni, Roberto; Taliani, Gloria; Ciccaglione, Anna Rita. - In: PATHOGENS AND GLOBAL HEALTH. - ISSN 2047-7724. - STAMPA. - 110:7-8(2016), pp. 275-276. [10.1080/20477724.2016.1255375]
Antiviral treatment of HBV positive pregnant women: an additional tool to reduce perinatal transmission
TALIANI, Gloria;
2016
Abstract
In a recent study published in New England Journal of Medicine, Pan and colleagues1 faced an important aspect for prevention of hepatitis B virus (HBV) infection: antiviral treatment with Tenofovir (TDF) during pregnancy to reduce perinatal transmission. This route of infection plays a crucial role for global diffusion of HBV, with frequency of chronic infection in mother-to-childtransmission (MTCT) of 90%| File | Dimensione | Formato | |
|---|---|---|---|
|
Bruni_antiviral-HBV_2016.pdf
accesso aperto
Tipologia:
Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
153.9 kB
Formato
Adobe PDF
|
153.9 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
